{
    "clinical_study": {
        "@rank": "104176", 
        "arm_group": [
            {
                "arm_group_label": "Immunosuppressed", 
                "description": "Immunosuppressed includes patients with any one of the following:\na diagnosis of a hematological malignancy\na diagnosis of HIV\nmyelosuppressive chemotherapy in the previous 90 days\nimmune-modulating medications in the previous 90 days"
            }, 
            {
                "arm_group_label": "Non-Immunosuppressed", 
                "description": "Subject does not fit immunosuppressed criteria"
            }
        ], 
        "biospec_descr": {
            "textblock": "Isolated monocytes from whole blood for HLA-DR measurement. Serum and plasma for cytokine\n      measurements"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine how monocyte HLA-DR and other markers of immune\n      function change with time in patients with and without prior immune dysfunction who survive\n      sepsis from Staphylococcus aureus bacteremia.\n\n      We hypothesize that patients with prior immune dysfunction will have greater reductions in\n      HLA-DR and other markers of immune function after an episode of sepsis than people who do\n      not have prior immune dysfunction."
        }, 
        "brief_title": "Immune Resolution After Staphylococcus Aureus Bacteremia", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Immune Response To Sepsis", 
            "Staphylococcus Aureus Infection"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Bacteremia", 
                "Sepsis", 
                "Staphylococcal Infections"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  At least one blood culture positive for S. aureus\n\n          -  Patients aged \u226518 years\n\n          -  At least two of four systemic inflammatory response syndrome (SIRS) criteria on the\n             day of positive blood cultures. SIRS criteria are:\n\n               -  Body temperature less than 36\u00b0C(96.8\u00b0F) or greater than 38\u00b0C(100.4\u00b0F)\n\n               -  Heart rate greater than 90 beats per minute\n\n               -  Tachypnea (high respiratory rate), with greater than 20 breaths per minute; or,\n                  an arterial partial pressure of carbon dioxide less than 32 mmHg\n\n               -  WBC less than 4000 cells/mm\u00b3 (4 x 109 cells/L) or greater than 12,000 cells/mm\u00b3\n                  (12 x 109 cells/L); or the presence of greater than 10% immature neutrophils\n                  (band forms)\n\n        Exclusion Criteria:\n\n          -  Sequential Organ Failure Assessment (SOFA) score > 12 on day of positive blood\n             cultures\n\n          -  Survival expected to be < 7 days from positive blood cultures"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Hospital inpatients with Staphylococcus aureus bacteremia who are over 18 years old."
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01879761", 
            "org_study_id": "13-0491"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Immunosuppressed", 
            "Sepsis", 
            "Staphylococcus Aureus", 
            "Bacteremia", 
            "HLA-DR"
        ], 
        "lastchanged_date": "March 12, 2014", 
        "location": {
            "contact": {
                "email": "jared.greenberg@uchospitals.edu", 
                "last_name": "Jared Greenberg, MD", 
                "phone": "773-702-1000"
            }, 
            "contact_backup": {
                "email": "jkress@medicine.bsd.uchicago.edu", 
                "last_name": "John Kress, MD", 
                "phone": "773-702-1000"
            }, 
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60637"
                }, 
                "name": "University of Chicago Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Jared A Greenberg, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "John P Kress, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Anne I Sperling, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Robert S Daum, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Michael Z David, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Bhakti K Patel, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Anne S Pohlman", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "other_outcome": {
            "measure": "Mortality", 
            "safety_issue": "No", 
            "time_frame": "0-90 days"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: University of Chicago IRB", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Percent expression of HLA-DR on monocytes will be measured by flow cytometry. Cytokine levels will be measured by ELISA.", 
            "measure": "HLA-DR and cytokines", 
            "safety_issue": "No", 
            "time_frame": "0-30 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01879761"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "New Infections", 
            "safety_issue": "No", 
            "time_frame": "0-90 days"
        }, 
        "source": "University of Chicago", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Chicago", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}